In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The price of Akebia Therapeutics Inc (NASDAQ: AKBA) closed at $3.64 in the last session, up 6.43% from day before closing price of $3.42. In other words, the price has increased by $6.43 from its previous closing price. On the day, 12.17 million shares were traded.
Ratios:
We take a closer look at AKBA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.02 and its Current Ratio is at 2.23. In the meantime, Its Debt-to-Equity ratio is 8.39 whereas as Long-Term Debt/Eq ratio is at 7.41.
On April 28, 2025, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $7.
On April 01, 2025, Jefferies started tracking the stock assigning a Buy rating and target price of $6.Jefferies initiated its Buy rating on April 01, 2025, with a $6 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 03 ’25 when Butler John P. sold 46,409 shares for $1.83 per share. The transaction valued at 84,928 led to the insider holds 2,557,921 shares of the business.
Burke Steven Keith sold 7,144 shares of AKBA for $13,074 on Mar 03 ’25. The SVP, Chief Medical Officer now owns 809,090 shares after completing the transaction at $1.83 per share. On Mar 03 ’25, another insider, Burke Steven Keith, who serves as the Officer of the company, bought 7,144 shares for $1.83 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 5.17 while its Price-to-Book (P/B) ratio in mrq is 38.74.
Stock Price History:
Over the past 52 weeks, AKBA has reached a high of $3.49, while it has fallen to a 52-week low of $0.80. The 50-Day Moving Average of the stock is 54.95%, while the 200-Day Moving Average is calculated to be 88.82%.
Shares Statistics:
A total of 261.64M shares are outstanding, with a floating share count of 251.86M. Insiders hold about 4.10% of the company’s shares, while institutions hold 36.53% stake in the company.
